TerminatedNot Applicable

Interest of EMDR Schizophrenic Disorders

Stopped: No patients included in the control group and inclusion rate too low.

France6 participantsStarted 2021-12-10

Plain-language summary

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 years and over, * Hospitalized for decompensated psychotic disorder, Positive diagnosis of schizophrenia or schizoaffective disorder (according to the DSM-V psychiatry manual), * With positive or negative symptoms according to the Positive and Negative Syndrome Scale (PANSS), * Stabilized clinical condition (considered compatible with hospital discharge), * With ambulatory follow-up planned after hospitalization Exclusion Criteria: * \< 18 years, * Patients who do not meet the diagnostic criteria (according to the DSM-V psychiatry manual) for schizophrenic or schizoaffective disorder), * Non-French speaking or illiterate patients, * Cognitive disorders making it impossible the understanding and the none- opposition to the study, * Non-stabilized clinical condition (incompatible with hospital discharge),

What they're measuring

Assessment of the decrease in the severity of positive or negative symptoms of schizophrenia

Timeframe: At 6 month after Hospital discharge (M0)

Trial details

NCT IDNCT05164289

SponsorHôpital NOVO

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-27

View on ClinicalTrials.gov More Schizophrenic Disorders trials